FLGT
NASDAQ
$19.61
Fulgent Genetics Inc (FLGT)
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $18.50 (-5.66%)
Market Cap
$606M
P/B Ratio
0.55
Free Cash Flow Yield
-18.67%
Beta (5Y)
0.66
Price Chart
Valuation
Market Cap$606M
Forward P/E7.70
P/S1.81
P/B0.55
Profitability
Total Revenue (TTM)$320M
Gross Profit (TTM)$124M
EBITDA-$82M
Profit Margin-34.9%
Operating Margin-48.7%
EPS-$2.45
Financial Health
Free Cash Flow Yield-18.67%
Growth & Risk
Revenue 5Y CAGR-16.16%
Beta (5Y)0.66
Sharpe Ratio0.40